VOGLIBOSE 0.3 MG MOUTH DISSOLVING

STRIP of 10 TAB.

Rx Prescription Required

VOGLIBOSE 0.3MG MOUTH DISSOLVING

Manufacturer : LIFE MAX CANCERIn StockProduct Code : GMP0315MRP : ₹ 94.00 (Inclusive of all taxes)₹ 34.0063.83% Off Quantity : Add Request

Product Details

VOGLIBOSE 0.3MG MOUTH DISSOLVING

Introduction :

Voglibose 0.3 MG mouth dissolving Tablet is used to lower blood glucose level in patients with Type 2 Diabetes Mellitus, especially when other medicines are not able to provide the desired results. It belongs to a group of medicines known as alpha-glucosidases inhibitors. This medication is used to control diabetes; it is not a cure. Other components of treatment plan are important: follow prescribed diet, medication, and exercise regimen. Take exactly as directed; with meal(s) at the same time each day. Do not change dose or discontinue without consulting prescriber. Avoid alcohol while taking this medication; could cause severe reaction. "

Indication :

Voglibose 0.3 MG Tablet is an anti-diabetic medicine. It is used to lower blood sugar levels if you have Type 2 Diabetes Mellitus (your body does not produce enough insulin or resist it Mouth dissolving tablets are designed to dissolve rapidly in the saliva, allowing for convenient administration without the need for water.

Administration :

Voglibose 0.3 MG Tablet exactly as prescribed by your doctor. It is advised to take this medicine just before meals.

Side Effects :

Diarrhoea Flatulence Pneumatosis Intestinalis Abnormal Liver Function Nausea Or Vomiting Dizziness

Contraindications :

Use of this medicine is not recommended during pregnancies as the possible effect on developing fetus is unknown. It is recommended to discontinue the consumption of this medicine if you are pregnant or planning to become pregnant. Consult your doctor before stopping the use of this medication so that an alternate medication can be prescribed.

References :

Voglibose - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2021 [cited 03 December 2021]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/444020 Voglibose - DrugBank [Internet]. Drugbank.ca. 2021 [cited 3 December 2021]. Available from: https://go.drugbank.com/drugs/DB04878

Mechanism of Action :

Voglibose inhibits alpha-glucosidase enzymes in the small intestine, delaying the digestion and absorption of carbohydrates. This results in a reduction in postprandial blood glucose levels.

Therapeutic :

Anti Diabetic

Disclaimer

At Genericart, our primary goal is to provide information that is thoroughly reviewed, accurate, and reliable. However, it is important to note that the content provided here should not be considered a substitute for professional medical advice. The information presented on our platform is intended for educational purposes only and may not cover all aspects of specific health conditions, medications, potential side effects, drug interactions, warnings, or alerts. We strongly encourage consulting with a qualified healthcare professional for advice and guidance regarding their health concerns and medication needs.